JP2014125436A - Foamy skin lotion - Google Patents
Foamy skin lotion Download PDFInfo
- Publication number
- JP2014125436A JP2014125436A JP2012281098A JP2012281098A JP2014125436A JP 2014125436 A JP2014125436 A JP 2014125436A JP 2012281098 A JP2012281098 A JP 2012281098A JP 2012281098 A JP2012281098 A JP 2012281098A JP 2014125436 A JP2014125436 A JP 2014125436A
- Authority
- JP
- Japan
- Prior art keywords
- foam
- skin
- polyoxyethylene
- acid
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006210 lotion Substances 0.000 title claims abstract description 38
- 239000006260 foam Substances 0.000 claims abstract description 95
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 239000002736 nonionic surfactant Substances 0.000 claims description 15
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 abstract description 10
- 238000005507 spraying Methods 0.000 abstract description 2
- -1 polyoxyethylene Polymers 0.000 description 109
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 49
- 238000005187 foaming Methods 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- 239000002537 cosmetic Substances 0.000 description 19
- 229920003169 water-soluble polymer Polymers 0.000 description 18
- 239000004359 castor oil Substances 0.000 description 17
- 235000019438 castor oil Nutrition 0.000 description 17
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 17
- 238000002156 mixing Methods 0.000 description 15
- 239000004166 Lanolin Substances 0.000 description 14
- 239000002202 Polyethylene glycol Substances 0.000 description 14
- 235000019388 lanolin Nutrition 0.000 description 14
- 229940039717 lanolin Drugs 0.000 description 14
- 229920001223 polyethylene glycol Polymers 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 238000011156 evaluation Methods 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000001993 wax Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 239000011550 stock solution Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229920001451 polypropylene glycol Polymers 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 5
- 229940097043 glucuronic acid Drugs 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 4
- 150000005215 alkyl ethers Chemical class 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000004088 foaming agent Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 3
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 3
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 3
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 229940059329 chondroitin sulfate Drugs 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 150000002009 diols Chemical class 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- IAJILQKETJEXLJ-LECHCGJUSA-N iduronic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-LECHCGJUSA-N 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229950006780 n-acetylglucosamine Drugs 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- FPJHWYCPAOPVIV-VOZMEZHOSA-N (2R,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-5-acetamido-2-(hydroxymethyl)-6-methoxy-3-sulfooxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CO[C@@H]1O[C@H](CO)[C@H](OS(O)(=O)=O)[C@H](O[C@@H]2O[C@H]([C@@H](OC)[C@H](O)[C@H]2O)C(O)=O)[C@H]1NC(C)=O FPJHWYCPAOPVIV-VOZMEZHOSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 2
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 2
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920000288 Keratan sulfate Polymers 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- ZAQJHHRNXZUBTE-UCORVYFPSA-N L-ribulose Chemical compound OC[C@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-UCORVYFPSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OVVGHDNPYGTYIT-VHBGUFLRSA-N Robinobiose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O1 OVVGHDNPYGTYIT-VHBGUFLRSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940073499 decyl glucoside Drugs 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 229940051593 dermatan sulfate Drugs 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229940009662 edetate Drugs 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 150000002337 glycosamines Chemical group 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229920006158 high molecular weight polymer Polymers 0.000 description 2
- 229940014041 hyaluronate Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- YZQGFCOUFDWVGL-RNHFCUEFSA-N (5r)-5-[(1s)-1,2-dihydroxyethyl]-5-ethyl-3,4-dihydroxyfuran-2-one Chemical compound OC[C@H](O)[C@@]1(CC)OC(=O)C(O)=C1O YZQGFCOUFDWVGL-RNHFCUEFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- NHJUPBDCSOGIKX-QMWFWAMKSA-N 1-O-(D-glucosyl)glycerol Chemical compound OCC(O)COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NHJUPBDCSOGIKX-QMWFWAMKSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000722941 Achillea Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- JPLATTLXZFUKRQ-UHFFFAOYSA-N Agarobiose Natural products OCC1OC(OC2C(O)COC2C(O)C=O)C(O)C(O)C1O JPLATTLXZFUKRQ-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- CAKGLMPBYAPFCR-UWBMNBDUSA-N Bemisiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 CAKGLMPBYAPFCR-UWBMNBDUSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N D-Arabitol Natural products OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical compound OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- UQPHVQVXLPRNCX-GSVOUGTGSA-N D-erythrulose Chemical compound OC[C@@H](O)C(=O)CO UQPHVQVXLPRNCX-GSVOUGTGSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 1
- 229930182847 D-glutamic acid Natural products 0.000 description 1
- ZGVNGXVNRCEBDS-HSUXUTPPSA-N D-hamamelose Chemical compound OC[C@@H](O)[C@@H](O)[C@](O)(CO)C=O ZGVNGXVNRCEBDS-HSUXUTPPSA-N 0.000 description 1
- ZGVNGXVNRCEBDS-UHFFFAOYSA-N D-hamamelose Natural products OCC(O)C(O)C(O)(CO)C=O ZGVNGXVNRCEBDS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WVZVXSGGSA-N L-xylulose Chemical compound OC[C@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-WVZVXSGGSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- NBGXQZRRLOGAJF-UHFFFAOYSA-N Maltulose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)(CO)OCC1O NBGXQZRRLOGAJF-UHFFFAOYSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 101710144121 Non-structural protein 5 Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- BUEBVQCTEJTADB-UHFFFAOYSA-N Sambubiose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)CO1 BUEBVQCTEJTADB-UHFFFAOYSA-N 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- GZCGUPFRVQAUEE-KAZBKCHUSA-N aldehydo-D-talose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KAZBKCHUSA-N 0.000 description 1
- PYMYPHUHKUWMLA-YUPRTTJUSA-N aldehydo-L-lyxose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-YUPRTTJUSA-N 0.000 description 1
- 150000001312 aldohexoses Chemical class 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-BTLHAWITSA-N alpha,beta-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-BTLHAWITSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- QIGJYVCQYDKYDW-KQBIKJCISA-N beta-D-Glcp-(1->3)-D-Galp Chemical compound OC[C@H]1O[C@@H](O[C@@H]2[C@@H](O)C(O)O[C@H](CO)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O QIGJYVCQYDKYDW-KQBIKJCISA-N 0.000 description 1
- WOHYVFWWTVNXTP-TWOHWVPZSA-N beta-D-fructofuranosyl-(2,1)-beta-D-fructofuranose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 WOHYVFWWTVNXTP-TWOHWVPZSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011538 cleaning material Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002574 ketohexoses Chemical class 0.000 description 1
- 150000002581 ketopentoses Chemical class 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- JCQLYHFGKNRPGE-HFZVAGMNSA-N maltulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-HFZVAGMNSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-N n-Decanedioic acid Natural products OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- OVVGHDNPYGTYIT-PEPLWKDOSA-N robinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-PEPLWKDOSA-N 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- OVVGHDNPYGTYIT-BNXXONSGSA-N rutinose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 OVVGHDNPYGTYIT-BNXXONSGSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- BUEBVQCTEJTADB-IGQSMMPPSA-N sambubiose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 BUEBVQCTEJTADB-IGQSMMPPSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- DFKDOZMCHOGOBR-UHFFFAOYSA-N zaragozic acid A Natural products O1C(C(O)(C(O2)C(O)=O)C(O)=O)(C(O)=O)C(OC(=O)C=CC(C)CC(C)CC)C(O)C21CCC(=C)C(OC(C)=O)C(C)CC1=CC=CC=C1 DFKDOZMCHOGOBR-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、泡沫状化粧水に関するものである。より詳しくは、ノンガスフォーマー容器に充填され、噴出される原液が泡沫状となり、手からこぼれることのない優れた泡質を形成し、肌に塗布した後に適度に泡沫が消失する機能を有し、低温下においても泡の形成性が良好で、ポンプ詰まりを起こしにくく、塗布後の肌のべたつきがなく、しっとりとした感触に優れる泡沫状化粧水に関する。 The present invention relates to a foam lotion. More specifically, the stock solution filled in the non-gas former container is foamed, forming an excellent foam quality that does not spill from the hand, and has the function of properly disappearing foam after it is applied to the skin. The present invention relates to a foam lotion that has good foam formation even at low temperatures, is less likely to cause pump clogging, has no stickiness of the skin after application, and has a moist feel.
泡沫状の化粧料は、使用時に塗布量が確認しやすく、また見かけ上の体積が大きいため、少ない量を広い範囲に塗布しやすい特徴を有している。泡沫状の化粧料には、噴出直後より泡を形成しているものや、噴出後しばらくして泡を形成するもの、原液をスプレー状に噴射させたのちに泡を形成させるものなど様々な形態があり、その剤型としては噴射ガスにより泡沫化するエアゾール剤と、吐出時に空気と混合する機構を持つノンガスタイプのポンプ式フォーマー剤がある。近年では、廃棄する時に環境に配慮する意識が向上しているのに対し、エアゾール剤は内容物、缶およびスパウトを分別して廃棄する手間が必要であり、使用後に内容物を詰め替えることができるリフィール機能を有していないという欠点があるため、ポンプ型泡吐出容器を用いたノンガスタイプのフォーマー剤の製品が増加している。例えば、メイク落とし等のクレンジング剤、洗顔料、ハンドソープ、ボディシャンプーなどのクレンジング料や洗浄料の分野ではポンプ式フォーマー容器の市販製品も増加傾向にある。尚、ポンプ動作により泡沫状に洗浄料を吐出するポンプ型泡吐出容器については、公知であり、また市販されている。(例えば、特許文献1〜5参照。) Foamed cosmetics are characterized in that the amount applied can be easily confirmed during use, and the apparent volume is large, so that a small amount can be easily applied over a wide range. There are various forms of foam-like cosmetics, such as those that form bubbles immediately after jetting, those that form foam some time after jetting, those that form foam after spraying the stock solution in spray form As the dosage form, there are an aerosol agent that is foamed by a propellant gas and a non-gas type pump former that has a mechanism of mixing with air at the time of discharge. In recent years, the awareness of the environment when disposing has increased, whereas aerosols require the trouble of separating and disposing of contents, cans and spouts, and can be refilled after use. Due to the disadvantage of not having a function, products of non-gas type formers using pump type foam discharge containers are increasing. For example, in the field of cleansing agents such as makeup removers, facial cleansers, hand soaps, body shampoos, and other cleansing and cleaning agents, commercial products of pump-type former containers are also increasing. In addition, the pump type foam discharge container which discharges the cleaning material in the form of foam by the pump operation is known and commercially available. (For example, see Patent Documents 1 to 5.)
しかしながら、化粧水、乳液および美容液などのスキンケア化粧品の分野では、市販されているポンプ式フォーマー容器の製品がほとんどない状況にある。これは、ポンプ式フォーマー容器を用いて泡沫状とするためには、従来、起泡剤となる界面活性剤を多量に配合する必要があり、多量の界面活性剤を配合することによって、皮膚刺激性が発生しやすく、また界面活性剤による脱脂効果によって保湿効果を十分に発揮させることができない、肌へのつっぱり感が発生するなどの点にある。更に、界面活性剤を多量に配合することにより、仮に起泡性が優れていても、肌に塗布した後に、適切なタイミングで泡が消失しないと、いつまでも肌の上に泡沫が残り、使用感に欠点を生じるため、起泡性と使用中の消泡性との泡質のコントロールが難しいことによる。更に、冬の低温下においては、ポンプ式フォーマー容器で吐出する界面活性剤の泡沫は、その形成能が弱くなるという欠点があり、低温下での起泡性と使用中の消泡性のバランスが困難であり、起泡性のバランスを解決する方法として、従来高分子ポリマーを配合するが、ノンガスフォーマー容器は機構上メッシュ詰りを起こしやすく、このようにスキンケアを目的としたノンガスフォーマー型の化粧料は、十分満足できる開発には至っていないのが現状である。泡沫状のスキンケア化粧料は塗布量が確認しやすい、見かけの体積が大きいため少ない量を広い範囲に塗布しやすく、手からこぼれ落ちない、コットンなどに含浸させなくても使用できて無駄がない等、簡便性と経済性に優れたノンガスフォーマー型の泡沫状化粧水の開発は強く望まれていたにもかかわらず、実現されていないのが現状である。 However, in the field of skin care cosmetics such as lotion, milky lotion, and cosmetic liquid, there are almost no products of pump-type former containers that are commercially available. In order to make a foam using a pump-type former container, conventionally, it is necessary to add a large amount of a surfactant as a foaming agent. By adding a large amount of a surfactant, It is easy to generate property, and the degreasing effect of the surfactant cannot sufficiently exert the moisturizing effect, and the skin feels tight. Furthermore, by adding a large amount of surfactant, even if the foaming property is excellent, if it does not disappear at the right time after applying to the skin, foam will remain on the skin indefinitely. This is because it is difficult to control the foam quality between the foaming property and the defoaming property during use. Furthermore, at low temperatures in winter, surfactant foam discharged from a pump-type former container has the disadvantage that its ability to form is weakened, and the balance between foaming properties at low temperatures and defoaming properties during use. As a method to solve the foaming balance, a conventional polymer is blended, but the non-gas former container is susceptible to mesh clogging due to its mechanism. Currently, the cosmetics have not been fully developed. Foamed skin care cosmetics are easy to check application amount, large apparent volume makes it easy to apply small amount over a wide range, does not spill from hands, can be used without impregnation with cotton etc. However, the development of a non-gas former type foamy lotion having excellent convenience and economy has been strongly desired, but it has not been realized.
一方、これらの課題を鑑みて、従来、泡沫状化粧料の種々の提案もなされており、例えば、N−長鎖アシル−α−アミノ酸またはその塩を用いたノンガスフォーマー用組成(例えば、特許文献6参照。)、非イオン界面活性剤3〜10重量%と多価アルコール2〜5重量%を組み合わせてなるポンプフォーマー用の泡沫形成組成物(例えば、特許文献7参照。)、水溶性アルコールと非イオン界面活性剤とN−アルキルピロリドンとを含有する泡沫状化粧料(例えば、特許文献8参照。)が開示されている。また、各種ポリマーを配合
することによって泡沫の状態を改善する試みがなされており、例えば、界面活性剤とヒドロキシエチルセルロースとポリオキシエチレンメチルポリシロキサン共重合体を組み合わせたノンエアゾール型泡状化粧料組成物(例えば、特許文献9参照。)、キサンタンガムとマルメロの種子を配合した泡沫形成化粧料(例えば、特許文献10参照。)が開示されている。また、サポニンと各種界面活性剤を含有することにより皮膚刺激の少ない起泡性清拭料(例えば、特許文献11参照。)が提案されている。
On the other hand, in view of these problems, various proposals for foamy cosmetics have been conventionally made. For example, compositions for non-gas formers using N-long chain acyl-α-amino acids or salts thereof (for example, patents) Reference 6)), a foam-forming composition for a pump former comprising 3 to 10% by weight of a nonionic surfactant and 2 to 5% by weight of a polyhydric alcohol (for example, see Patent Document 7), water-soluble. A foamy cosmetic (for example, see Patent Document 8) containing alcohol, a nonionic surfactant and N-alkylpyrrolidone is disclosed. Also, attempts have been made to improve the foam state by blending various polymers. For example, a non-aerosol foam cosmetic composition comprising a combination of a surfactant, hydroxyethyl cellulose and a polyoxyethylene methyl polysiloxane copolymer. Products (for example, see Patent Document 9), foam-forming cosmetics (see, for example, Patent Document 10) containing xanthan gum and quince seeds are disclosed. In addition, a foaming wiping agent (see, for example, Patent Document 11) with less skin irritation by containing saponin and various surfactants has been proposed.
しかしながら、特許文献6に記載のノンガスフォーマー用組成では、N−長鎖アシルアミノ酸塩を2.5〜20重量%配合することによって、クリーミィな泡を実現しているものの、界面活性剤の配合量が多いため、これをスキンケア化粧料に応用した場合、消泡性がないために、いつまでも顔面に泡沫が残り、更にアニオン界面活性剤を使用しているために脱脂力が強く、化粧水として必要な機能であるしっとり感を実現できないという課題がある。特許文献7記載のポンプフォーマー用の泡沫形成組成物においては、皮膚刺激等を考慮して非イオン界面活性剤を使用しているが、その配合量は3〜10重量%と高く、高濃度の界面活性剤を配合したことにより、消泡性がないために、いつまでも顔面に泡沫が残ってしまい、また塗布乾燥後のべたつきを生じる。この発明はクレンジング等の洗浄組成物には適しているものの、スキンケア化粧料には適していない課題がある。特許文献8に記載の泡沫状化粧料では、水溶性アルコールと低濃度の界面活性剤をバランス良く配合するにより、泡質と泡の持続性を形成し、ポンプ式のフォーマーに充填して用いることも可能であるとの記載があるが、この発明は実質、LPGなどの噴射剤を配合することが前提となった発明であり、この発明の実施例をポンプ式フォーマー容器に充填して評価した場合、荒い泡質となり、泡沫がすぐに消失する持続性に欠けるものであり、スキンケア化粧料として応用するには使用感において十分満足できない課題がある。また、特許文献9に記載の泡沫状化粧料は、ポリオキシエチレンメチルポリシロキサンを起泡剤として利用し、高分子ポリマーを配合することによって、一定の起泡力の改善はあるものの、泡質が荒く、特に、ポリオキシエチレンメチルポリシロキサンを起泡剤として使用した場合には、エタノールを配合しないとこの発明の効果は発現されず、高濃度のエタノールの配合は、皮膚刺激となる課題がある。また特許文献10に記載の泡沫状化粧料は、LPGなどの噴射剤を配合することが前提となった発明であり、この発明の実施例をポンプ式フォーマー容器に充填して評価した場合、泡が形成されず、ポンプ型泡吐出容器を想定されていない。また、特許文献11に記載の泡沫状清拭料では、サポニンを起泡剤として利用し、高い起泡性を有し、拭き取るタイプの清拭料として優れているものの、泡切れが悪く、また界面活性剤の配合量も多く、スキンケア化粧料に応用した場合、べたつきを生じて使用感触として十分満足できるものに至っておらず、また低温下で起泡性が消失するという課題
がある。
However, in the composition for non-gas former described in Patent Document 6, a creamy foam is realized by adding 2.5 to 20% by weight of an N-long chain acylamino acid salt. When applied to skin care cosmetics due to the large amount, there is no defoaming property, so foam remains on the face indefinitely, and since an anionic surfactant is used, the degreasing power is strong, and as a lotion There is a problem that a moist feeling that is a necessary function cannot be realized. In the foam forming composition for a pump former described in Patent Document 7, a nonionic surfactant is used in consideration of skin irritation and the like, but its blending amount is as high as 3 to 10% by weight, and the concentration is high. When the surfactant is added, since there is no defoaming property, foam remains on the face forever, and stickiness after coating and drying occurs. Although this invention is suitable for cleaning compositions such as cleansing, there is a problem that it is not suitable for skin care cosmetics. In the foamy cosmetic described in Patent Document 8, the foam quality and the persistence of the foam are formed by mixing the water-soluble alcohol and the low-concentration surfactant in a balanced manner, and the foam-type cosmetic is filled in a pump-type former. However, this invention is substantially based on the premise that a propellant such as LPG is blended, and the embodiment of the present invention was filled into a pump-type former container and evaluated. In such a case, the foam quality is rough, and the foam disappears quickly, and there is a problem that the feeling of use cannot be sufficiently satisfied for application as a skin care cosmetic. In addition, the foam cosmetic described in Patent Document 9 uses polyoxyethylene methylpolysiloxane as a foaming agent and blends a high molecular weight polymer with a certain improvement in foaming power. In particular, when polyoxyethylene methylpolysiloxane is used as a foaming agent, the effect of the present invention is not expressed unless ethanol is blended, and blending of high-concentration ethanol has the problem of causing skin irritation. is there. Further, the foam cosmetic described in Patent Document 10 is an invention based on the premise that a propellant such as LPG is blended. When the embodiment of this invention is evaluated by filling a pump-type former container, Is not formed, and a pump-type foam discharge container is not assumed. Moreover, in the foamy wiping material described in Patent Document 11, although saponin is used as a foaming agent, it has high foaming properties and is excellent as a wiping type of wiping off, but it is poor in foaming and has a surface activity. There are also many compounding amounts of the agent, and when applied to skin care cosmetics, there is a problem that it is not sticky enough to satisfy the feeling of use and the foaming properties disappear at low temperatures.
従って、本発明の課題は、ノンガスフォーマー容器に充填され、噴出される原液が泡沫状となり、手からこぼれることのない泡質を形成することによって、コットン等を用いることなく化粧水を肌に塗布することができ、また、肌へ塗布した後にマッサージすることによって適度に泡が消失して、泡が肌に残存しない機能を有する使用時の簡便性に優れ、更に低温下においても泡の形成性が良好であり、ポンプ詰まりが起こることがなく、塗布後は肌がべたつくことなく、しっとりとした感触に優れ、皮膚刺激の少ない泡沫状化粧水を提供することにある。 Accordingly, an object of the present invention is to fill the skin with a lotion without using cotton or the like by forming a foam that fills a non-gas former container and the jetted stock solution becomes foamy and does not spill from the hands. It can be applied, and after applying to the skin, the foam disappears moderately and the foam does not remain on the skin. An object of the present invention is to provide a foam lotion that has good properties, does not cause clogging of the pump, does not become sticky after application, has a moist feel, and has little skin irritation.
本発明者等は、上記課題を解決するために鋭意研究を重ねた結果、アルキルポリグルコシドと、特定のHLB値を有する非イオン界面活性剤と、多価アルコールとを組み合わせた液状の組成物をノンガスフォーマー容器に充填することにより、噴出される原液が泡沫状となり、手からこぼれることのない泡質を形成し、肌に塗布後にマッサージすることによって泡が消失する機能を有し、更に低温下においても泡の形成性が良好で、ポンプ詰まりも起こることがなく、塗布後べたつくことなく、しっとりとした感触に優れる泡沫状化粧水が得られることを見出し、本発明を完成するに至った。 As a result of intensive studies to solve the above problems, the present inventors have obtained a liquid composition comprising a combination of an alkylpolyglucoside, a nonionic surfactant having a specific HLB value, and a polyhydric alcohol. By filling the non-gas former container, the sprayed stock solution becomes foamy, forms a foam that does not spill from the hand, and has the function of disappearing foam by massaging after application to the skin. It was found that a foamy skin lotion with good foam formation, no clogging of the pump, no stickiness after application, and a moist feel was obtained, and the present invention was completed. .
即ち本発明は、次の成分(A)、(B)および(C)を含有し、(A)と(B)の合計量が0.3〜1質量%である液状の組成物をノンガスフォーマー容器に充填したことを特徴とする泡沫状化粧水である。
(A)アルキルポリグルコシド
(B)HLB値が12〜15の非イオン界面活性剤
(C)多価アルコール
That is, the present invention provides a liquid composition containing the following components (A), (B) and (C), wherein the total amount of (A) and (B) is 0.3 to 1% by mass. It is a foamy skin lotion that is filled in a mer container.
(A) Alkyl polyglucoside (B) Nonionic surfactant having an HLB value of 12 to 15 (C) Polyhydric alcohol
本発明の泡沫状化粧水は、ノンガスフォーマー容器に充填され、噴出される原液が泡沫状となり、手からこぼれることのない泡質を形成し、肌に塗布後にマッサージすることによって泡が消失する機能を有し、更に低温下においても泡の形成性が良好で、ポンプ詰まりも起こることがなく、塗布後べたつくことなく、しっとりとした感触に優れる泡沫状化粧水が提供される。 The foamy lotion of the present invention is filled in a non-gas former container, and the sprayed stock solution becomes foamy, forms a foam that does not spill from the hand, and foam disappears by massaging after application to the skin There is provided a foam lotion that has a function, has good foam formation even at low temperatures, does not clog pumps, does not become sticky after application, and has a moist feel.
以下、本発明について詳述する。 Hereinafter, the present invention will be described in detail.
本発明で使用する成分(A)アルキルポリグルコシドは、ノンガスフォーマー容器から吐出される原液を泡沫状とする起泡成分の一つであり、塗布後の肌にべたつき感を残さない感触特徴を有する目的で配合される。アルキルポリグルコシドとしては、アルキルグルコシド、アルキルポリグリコシドと称されるものも含み、下記一般式(I)で表される。 The component (A) alkylpolyglucoside used in the present invention is one of the foaming components in which the stock solution discharged from the non-gas former container is foamed, and has a touch characteristic that does not leave a sticky feeling on the skin after application. It is blended for the purpose of having. The alkyl polyglucoside includes those called alkyl glucoside and alkyl polyglycoside, and is represented by the following general formula (I).
Glu−(Glu)nOR ・・・(I)
(式中、Gluはグルコース基、nは重合度、Rはアルキル基を表す。)
Glu- (Glu) nOR (I)
(In the formula, Glu represents a glucose group, n represents a polymerization degree, and R represents an alkyl group.)
上記一般式(I)において、Rのアルキル基の炭素数は8〜18で、好ましくは10〜14であり、グルコースの重合度nは0〜2であるものが好ましい。このようなアルキルポリグルコシドを具体的に例示すると、オクチルポリグルコシド、2−エチルヘキシルポリグルコシド、デシルポリグルコシド、ラウリルポリグルコシド、ヤシ油アルコールポリグルコシド、ミリスチルポリグルコシド、パルミチルポリグルコシド、イソステアリルポリグルコシド、ステアリルラウリルポリグルコシド、オレイルポリグルコシド、ベヘニルポ
リグルコシド等が挙げらる。これらアルキルポリグルコシドは、PLANTACARE 1200UP、PLANTACARE 2000UP、PLANTACARE 818UP、グルコポン 600UP(コグニス社製)、Oramix NS10、Oramix
NS26(SEPPIC社製)、マイドール10、マイドール12(花王社製)などが商業的に入手でき、本発明においては、これらの中から一種又は二種以上を組み合わせて配合することができる。
In the said general formula (I), carbon number of the alkyl group of R is 8-18, Preferably it is 10-14, and the polymerization degree n of glucose is 0-2. Specific examples of such alkyl polyglucosides include octyl polyglucoside, 2-ethylhexyl polyglucoside, decyl polyglucoside, lauryl polyglucoside, coconut oil alcohol polyglucoside, myristyl polyglucoside, palmityl polyglucoside, isostearyl polyglucoside. , Stearyl lauryl polyglucoside, oleyl polyglucoside, behenyl polyglucoside and the like. These alkylpolyglucosides are PLANTACARE 1200UP, PLANTACARE 2000UP, PLANTACARE 818UP, Glucopone 600UP (manufactured by Cognis), Oramix NS10, Oramix.
NS26 (manufactured by SEPPIC), Mydoll 10, Mydoll 12 (manufactured by Kao) and the like are commercially available, and in the present invention, one or a combination of two or more of these can be blended.
これらのアルキルポリグルコシドのうち、デシルポリグルコシド、ラウリルポリグルコシド、ヤシ油アルコールポリグルコシドが泡沫の形成性、肌に塗布した後にマッサージすることによる泡の消失性、低温下での泡の形成性、塗布後のべたつきのなの点で好ましく、さらにデシルポリグルコシドが泡沫の形成性とべたつきのなさの点で特に好ましい。 Among these alkyl polyglucosides, decyl polyglucoside, lauryl polyglucoside, coconut oil alcohol polyglucoside form foam, disappearance of foam by massaging after applying to the skin, foam formation under low temperature, It is preferable in terms of stickiness after application, and decylpolyglucoside is particularly preferable in terms of foam formation and non-stickiness.
本発明におけるアルキルポリグルコシドの好ましい配合量としては、組成物中に0.05〜0.5質量%(以下、単に%と略す)であり、特に好ましくは0.1〜0.3%である。アルキルポリグルコシドの配合量が0.05%未満であると優れた起泡性が得られない場合があり、また配合量が0.5%を超えると泡の消失性が悪くなる場合があり、その場合はいつまでも皮膚上に泡沫が残りやすく違和感を生じることがある。 A preferred blending amount of the alkylpolyglucoside in the present invention is 0.05 to 0.5% by mass (hereinafter simply referred to as “%”) in the composition, and particularly preferably 0.1 to 0.3%. . If the blending amount of the alkyl polyglucoside is less than 0.05%, excellent foaming properties may not be obtained, and if the blending amount exceeds 0.5%, the foam disappearance may be deteriorated, In that case, foam may remain on the skin indefinitely and may cause a sense of incongruity.
本発明で使用する成分(B)HLB値が12〜15の非イオン界面活性剤は、ノンガスフォーマー容器から吐出される原液を泡沫状とした際に起泡状態を調整する成分であり、特に肌に塗布した後の泡の消泡性を調整し、また肌にべたつきがない感触を与える目的で配合される。また、HLB値が13〜14の非イオン界面活性剤が、泡のクリーミーさ、適度な消泡効果、使用後のべたつきのなさ等の感触面で更に好ましい。HLB値が12未満の場合、親油性が高いため本発明においては泡沫を形成しないか、あるいは泡沫を形成してもすぐに泡沫が消えてしまい使用上の問題が生じやすく、また、HLB値が15を超えた場合、泡沫の形成性は優れているが、肌の上で消失しない泡沫が形成されて使用感が非常に悪く、本発明の目的を達成できない。尚、HLB値とは、親水性−親油性のバランス(Hydrophilic−Lypophilic Balance)を示す指標であり、本発明においては、小田・寺村らによる次式を用いて算出した値を用いている。 The component (B) nonionic surfactant having an HLB value of 12 to 15 used in the present invention is a component that adjusts the foaming state when the stock solution discharged from the non-gas former container is foamed, particularly It is formulated for the purpose of adjusting the defoaming property of the foam after being applied to the skin and giving the skin a non-sticky feel. A nonionic surfactant having an HLB value of 13 to 14 is more preferable in terms of feel such as foam creaminess, moderate defoaming effect, and non-stickiness after use. When the HLB value is less than 12, since the lipophilicity is high, in the present invention, no foam is formed, or even if the foam is formed, the foam disappears immediately and a problem in use tends to occur, and the HLB value is When it exceeds 15, the foam formability is excellent, but a foam that does not disappear on the skin is formed and the feeling of use is very poor, and the object of the present invention cannot be achieved. The HLB value is an index indicating a hydrophilic-lipophilic balance. In the present invention, a value calculated using the following equation by Oda / Teramura et al. Is used.
HLB値=(Σ無機性値/Σ有機性値)×10 HLB value = (Σinorganic value / Σorganic value) × 10
上記HLB値が12〜15の非イオン界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンヒマシ油、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリエチレングリコール脂肪酸エステル、ポリグリセリン脂肪酸エステル等が挙げられる。これらのHLB値が12〜15の非イオン界面活性剤を具体的に例示すると、ポリオキシエチレン硬化ヒマシ油としては、ポリオキシエチレン硬化ヒマシ油(40E.O.)、ポリオキシエチレン硬化ヒマシ油(50E.O.)、ポリオキシエチレン硬化ヒマシ油(60E.O.)、ポリオキシエチレン硬化ヒマシ油(80E.O.)等が挙げられる。ポリオキシエチレンヒマシ油としては、ポリオキシエチレンヒマシ油(40E.O.)、ポリオキシエチレンヒマシ油(50E.O.)、ポリオキシエチレンヒマシ油(60E.O.)等が挙げられる。 Nonionic surfactants having an HLB value of 12 to 15 include polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbite fatty acid ester, polyoxyethylene alkyl ether, polyethylene Examples include glycol fatty acid esters and polyglycerin fatty acid esters. Specific examples of these nonionic surfactants having an HLB value of 12 to 15 include polyoxyethylene hydrogenated castor oil (40E.O.), polyoxyethylene hydrogenated castor oil ( 50E.O.), polyoxyethylene hydrogenated castor oil (60E.O.), polyoxyethylene hydrogenated castor oil (80E.O.), and the like. Examples of the polyoxyethylene castor oil include polyoxyethylene castor oil (40E.O.), polyoxyethylene castor oil (50E.O.), polyoxyethylene castor oil (60E.O.), and the like.
ポリオキシエチレングリセリン脂肪酸エステルとしては、モノステアリン酸ポリオキシエチレングリセリル(15E.O.)、モノステアリン酸ポリオキシエチレングリセリル(20E.O.)、モノステアリン酸ポリオキシエチレングリセリル(25E.O.)、モノイソステアリン酸ポリオキシエチレングリセリル(15E.O.)、モノイソステアリン酸ポリオキシエチレングリセリル(20E.O.)、モノイソステアリン酸ポリオキシエチレングリセリル(25E.O.)、オレイン酸ポリオキシエチレングリセリル(10
E.O.)、モノオレイン酸ポリオキシエチレングリセリル(15E.O.)、ジイソステアリン酸ポリオキシエチレングリセリル(30E.O.)、ジイソステアリン酸ポリオキシエチレングリセリル(40E.O.)、ジイソステアリン酸ポリオキシエチレングリセリル(50E.O.)、トリイソステアリン酸ポリオキシエチレングリセリル(50E.O.)、トリイソステアリン酸ポリオキシエチレングリセリル(60E.O.)、トリオレイン酸ポリオキシエチレングリセリル(50E.O.)、トリオレイン酸ポリオキシエチレングリセリル(60E.O.)等が挙げられる。
Examples of the polyoxyethylene glycerin fatty acid ester include polyoxyethylene glyceryl monostearate (15E.O.), polyoxyethylene glyceryl monostearate (20E.O.), and polyoxyethylene glyceryl monostearate (25E.O.). , Polyisoethylene glyceryl monoisostearate (15 EO), polyoxyethylene glyceryl monoisostearate (20 EO), polyoxyethylene glyceryl monoisostearate (25 EO), polyoxyethylene glyceryl oleate ( 10
E. O. ), Polyoxyethylene glyceryl monooleate (15 EO), polyoxyethylene glyceryl diisostearate (30 EO), polyoxyethylene glyceryl diisostearate (40 EO), polyoxyethylene glyceryl diisostearate (50E) O.), polyoxyethylene glyceryl triisostearate (50 EO), polyoxyethylene glyceryl triisostearate (60 EO), polyoxyethylene glyceryl trioleate (50 EO), trioleic acid And polyoxyethylene glyceryl (60E.O.).
ポリオキシエチレンソルビット脂肪酸エステルとしては、テトラオレイン酸ポリオキシエチレンソルビタン(40E.O.)、テトラオレイン酸ポリオキシエチレンソルビタン(60E.O.)、モノステアリン酸ポリオキシエチレンソルビタン(20E.O.)、モノイソステアリン酸ポリオキシエチレンソルビタン(20E.O.)、モノオレイン酸ポリオキシエチレンソルビタン(20E.O.)等が挙げられる。 Examples of the polyoxyethylene sorbit fatty acid ester include polyoxyethylene sorbitan tetraoleate (40E.O.), polyoxyethylene sorbitan tetraoleate (60E.O.), and polyoxyethylene sorbitan monostearate (20E.O.). , Monoisostearic acid polyoxyethylene sorbitan (20E.O.), monooleic acid polyoxyethylene sorbitan (20E.O.), and the like.
ポリオキシエチレンアルキルエーテルとしては、ポリオキシエチレンセチルエーテル(10E.O.)、ポリオキシエチレン2級アルキルエーテル(7E.O.)、ポリオキシエチレン2級アルキルエーテル(9E.O.)、ポリオキシエチレン水添ダイマージオール(30E.O.)、ポリオキシエチレン水添ダイマージオール(40E.O.)、ポリオキシエチレン水添ダイマージオール(50E.O.)、ポリオキシエチレンデシルテトラデシルエーテル(20E.O.)、ポリオキシエチレンデシルテトラデシルエーテル(25E.O.)、ポリオキシエチレンデシルテトラデシルエーテル(30E.O.)、ポリオキシエチレンラウリルエーテル(7〜15E.O.)、ポリオキシエチレンオレイルエーテル(10E.O.)、ポリオキシエチレンラノリンアルコール(5E.O.)、ポリオキシエチレンラノリンアルコール(10E.O.)、ポリオキシエチレンフィトステロール(10E.O.)、ポリオキシエチレンフィトステロール(20E.O.)、ポリオキシエチレン(20E.O.)ポリオキシプロピレン(8P.O.)セチルエーテル、ポリオキシエチレン(12E.O.)ポリオキシプロピレン(6P.O.)デシルテトラデシルエーテル、リオキシエチレン(30E.O.)ポリオキシプロピレン(6P.O.)デシルテトラデシルエーテル等が挙げられる。 Examples of the polyoxyethylene alkyl ether include polyoxyethylene cetyl ether (10E.O.), polyoxyethylene secondary alkyl ether (7E.O.), polyoxyethylene secondary alkyl ether (9E.O.), polyoxyethylene Ethylene hydrogenated dimer diol (30E.O.), polyoxyethylene hydrogenated dimer diol (40E.O.), polyoxyethylene hydrogenated dimer diol (50E.O.), polyoxyethylene decyl tetradecyl ether (20E.O.) O.), polyoxyethylene decyl tetradecyl ether (25E.O.), polyoxyethylene decyl tetradecyl ether (30E.O.), polyoxyethylene lauryl ether (7-15E.O.), Polyoxyethylene oleyl Ether (10E.O.), poly Oxyethylene lanolin alcohol (5E.O.), polyoxyethylene lanolin alcohol (10E.O.), polyoxyethylene phytosterol (10E.O.), polyoxyethylene phytosterol (20E.O.), polyoxyethylene (20E) .O.) Polyoxypropylene (8PO) cetyl ether, polyoxyethylene (12E.O.) polyoxypropylene (6PO) decyltetradecyl ether, reoxyethylene (30E.O.) polyoxy Propylene (6P.O.) decyl tetradecyl ether and the like.
ポリエチレングリコール脂肪酸エステルとしては、モノラウリン酸ポリエチレングリコール(8E.O.)、モノラウリン酸ポリエチレングリコール(12E.O.)、モノステアリン酸ポリエチレングリコール(15E.O.)、モノステアリン酸ポリエチレングリコール(20E.O.)、モノステアリン酸ポリエチレングリコール(25E.O.)、モノイソステアリン酸ポリエチレングリコール(12E.O.)、モノイソステアリン酸ポリエチレングリコール(20E.O.)等が挙げられる。 Examples of polyethylene glycol fatty acid esters include polyethylene glycol monolaurate (8E.O.), polyethylene glycol monolaurate (12E.O.), polyethylene glycol monostearate (15E.O.), polyethylene glycol monostearate (20E.O.). .), Polyethylene glycol monostearate (25E.O.), polyethylene glycol monoisostearate (12E.O.), polyethylene glycol monoisostearate (20E.O.), and the like.
ポリグリセリン脂肪酸エステルとしては、モノオレイン酸デカグリセリル、モノイソステアリン酸デカグリセリル、モノミリスチン酸デカグリセリル、モノステアリン酸デカグリセリル、モノリノール酸デカグリセリル等が挙げられる。本発明においては、これらHLB値が12〜15の非イオン界面活性剤の中から一種又は二種以上を組み合わせて配合することができる。 Examples of the polyglycerol fatty acid ester include decaglyceryl monooleate, decaglyceryl monoisostearate, decaglyceryl monomyristate, decaglyceryl monostearate, decaglyceryl monolinoleate and the like. In the present invention, these non-ionic surfactants having an HLB value of 12 to 15 can be used alone or in combination of two or more.
これらのHLB値が12〜15の非イオン界面活性剤のうち、HLB値が13〜14のポリオキシエチレン硬化ヒマシ油、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステルが泡のクリーミーさ、適度な消泡効果、使用後のべたつきのなさ等の感触面で好ましく、さらにHLB値が13〜14のポリオキシエチレン硬化ヒマシ油が起泡性、泡質および消泡効果の点で特に好ましい。 Among these nonionic surfactants having an HLB value of 12 to 15, polyoxyethylene hydrogenated castor oil having an HLB value of 13 to 14, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sorbite fatty acid ester is creamy foam, A suitable defoaming effect and a feeling such as non-stickiness after use are preferred, and polyoxyethylene hydrogenated castor oil having an HLB value of 13 to 14 is particularly preferred in terms of foamability, foam quality and defoaming effect.
本発明におけるHLB値が12〜15の非イオン界面活性剤の好ましい配合量としては、
全組成物中に0.05〜0.5%であり、特に好ましくは0.1〜0.3%である。非イオン界面活性剤の配合量が0.05%未満であると泡のクリーミーさと適度な泡の消泡性が得られない場合があり、また配合量が0.5%を超えると起泡性に悪影響を与える場合や、塗布後の肌にべたつきを生じて感触的に好ましくない場合がある。
As a preferable blending amount of the nonionic surfactant having an HLB value of 12 to 15 in the present invention,
It is 0.05 to 0.5% in the total composition, and particularly preferably 0.1 to 0.3%. If the blending amount of the nonionic surfactant is less than 0.05%, foam creamy and moderate foam defoaming properties may not be obtained. If the blending amount exceeds 0.5%, foaming properties may be obtained. May be adversely affected, or may be sticky on the skin after application, which is undesirable in touch.
本発明においては成分(A)アルキルポリグルコシドと成分(B)HLB値が12〜15の非イオン界面活性剤の合計量が全組成物中に0.3〜1%であり、更に好ましくは0.4〜0.8%である。成分(A)と成分(B)の合計量が0.3%未満であると起泡性と適度な泡の持続性を得られず、また配合量が1%を超えると塗布後の肌にべたつきを生じて感触的に好ましくない。 In the present invention, the total amount of the component (A) alkylpolyglucoside and the component (B) nonionic surfactant having an HLB value of 12 to 15 is 0.3 to 1% in the total composition, more preferably 0. .4 to 0.8%. If the total amount of the component (A) and the component (B) is less than 0.3%, foaming properties and appropriate foam persistence cannot be obtained. It is sticky and unfavorable to the touch.
本発明で使用する成分(C)多価アルコールは、ノンガスフォーマー容器から噴出される化粧水の泡沫を安定化し、肌に塗布した後に消泡する機能、また塗布後の肌のしっとり感を与える目的で配合される。本発明における多価アルコールは、アルコール性水酸基を分子構造内に2個以上有するアルコール、単糖類、二糖類及び糖アルコールを示す。 The component (C) polyhydric alcohol used in the present invention stabilizes the foam of the skin lotion ejected from the non-gas former container, and gives a function of defoaming after application to the skin, and a moist feeling of the skin after application. Formulated for the purpose. The polyhydric alcohol in this invention shows the alcohol, monosaccharide, disaccharide, and sugar alcohol which have 2 or more of alcoholic hydroxyl groups in a molecular structure.
2価以上のアルコールの具体例としては、プロピレングリコール、ポリプロピレングリコール、1,3−ブチレングリコール、ジプロピレングリコール、イソプレングリコール、ヘキシレングリコール、1,2−ペンタンジオール、エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール、グリセリン、ジグリセリン、ポリグリセリン、ポリエチレングリコールモノエチルエーテル、ジエチレングリコールモノエチルエーテル、エチレングリコールジメチルエーテル、ポリオキシエチレン(14E.O.)ポリオキシプロピレン(7P.O.)ジメチルエーテル、ポリオキシエチレン(17E.O.)ポリオキシプロピレン(4P.O.)ジメチルエーテルなどが挙げられる。 Specific examples of the dihydric or higher alcohol include propylene glycol, polypropylene glycol, 1,3-butylene glycol, dipropylene glycol, isoprene glycol, hexylene glycol, 1,2-pentanediol, ethylene glycol, diethylene glycol, and triethylene glycol. , Polyethylene glycol, glycerin, diglycerin, polyglycerin, polyethylene glycol monoethyl ether, diethylene glycol monoethyl ether, ethylene glycol dimethyl ether, polyoxyethylene (14E.O.) polyoxypropylene (7P.O.) dimethyl ether, polyoxyethylene (17E.O.) polyoxypropylene (4P.O.) dimethyl ether and the like.
単糖類の具体例としては、D−エリツルロース,D−エリトロース,D−トレオース等のテトロース類、D−アラビノース,L−アラビノース,D−キシロース,D−リキソース,L−リキソース,D−リボース等のアルドペントース類、D−キシルロース,L−キシルロース,D−リブロース,L−リブロース等のケトペントース類、D−ガラクトース,L−ガラクトース,D−グルコース,D−タロース,D−マンノース等のアルドヘキソース類、L−ソルボース,D−タガトース,D−プシコース,D−フルクトース等のケトヘキソース類、D−アピオース,D−ハマメロース等の分枝糖類などが挙げられる。 Specific examples of monosaccharides include aldoses such as D-erythrulose, D-erythrose, D-threose, etc., D-arabinose, L-arabinose, D-xylose, D-lyxose, L-lyxose, D-ribose, etc. Pentoses, ketopentoses such as D-xylulose, L-xylulose, D-ribulose, L-ribulose, aldohexoses such as D-galactose, L-galactose, D-glucose, D-talose, D-mannose, L- Examples thereof include ketohexoses such as sorbose, D-tagatose, D-psicose and D-fructose, and branched sugars such as D-apiose and D-hamamelose.
二糖類の具体例としては、キシロビオース,アガロビオース,カラビオース,マルトース,イソマルトース,ソホロース,セロビオース,トレハロース,ネオトレハロース,イソトレハロース,イヌロビオース,ビシアノース,イソプリメベロース,サンブビオース,プリメベロース,ソラビオース,メリビオース,ラクトース,リコビオース,エピセロビオース,スクロース,ツラノース,マルツロース,ラクツロース,エピゲンチビオース,ロビノビオース,シラノビオース,ルチノース等が挙げられる。 Specific examples of disaccharides include xylobiose, agarobiose, carabiose, maltose, isomaltose, sophorose, cellobiose, trehalose, neotrehalose, isotrehalose, inulobiose, vicyanose, isoprimebellose, sambubiose, primebellose, solabiose, melibiose, Examples include lycobiose, epicellobiose, sucrose, turanose, maltulose, lactulose, epigentibose, robinobiose, silanobiose, and rutinose.
糖アルコールの具体例としては、エリスリトール,D−アラビトール,キシリトール,D−リビトール,ガラクチトール,D−グルシトール,D−マンニトール,マルチトール、グルコシルグリセリン、トレハロース、グルコシルトレハロース等が挙げられる。 Specific examples of the sugar alcohol include erythritol, D-arabitol, xylitol, D-ribitol, galactitol, D-glucitol, D-mannitol, maltitol, glucosylglycerin, trehalose, glucosyltrehalose and the like.
これらの多価アルコールは、一種又は二種以上を組み合わせて配合することができる。これら多価アルコールのうち、1,3−ブチレングリコール、ジプロピレングリコール、グリセリン、ジグリセリン、ポリグリセリン、イソプレングリコール、ポリエチレングリコール、マルチトール、ソルビトールが化粧水の泡沫を安定化し、肌に塗布した後に消泡する機能、また塗布後の肌のしっとり感を与え好ましい。また、1,3−ブチレングリコー
ル、ジプロピレングリコール、イソプレングリコール、ポリエチレングリコールは、ノンガスフォーマーの中でもポンプ型泡沫吐出容器において、容器部品内での乾燥凝集によるポンプの作動性を改善する効果を有しさらに好ましい。
These polyhydric alcohols can be blended singly or in combination of two or more. Among these polyhydric alcohols, after 1,3-butylene glycol, dipropylene glycol, glycerin, diglycerin, polyglycerin, isoprene glycol, polyethylene glycol, maltitol, sorbitol stabilizes the foam of skin lotion and applied to the skin The function of defoaming and the moist feeling of the skin after application are preferred. In addition, 1,3-butylene glycol, dipropylene glycol, isoprene glycol, and polyethylene glycol have the effect of improving pump operability due to dry agglomeration in the container parts of non-gas formers in pump type foam discharge containers. More preferred.
本発明における多価アルコールの好ましい配合量としては、全組成物中に1〜20%であり、特に好ましくは5〜15%である。多価アルコールの配合量が1%未満であると泡のクリーミーさと適度な泡の安定性が得られず、また塗布後の肌のしっとり感が不足し、べたつき感を生じる場合があり、また配合量が20%を超えるとかえって起泡性に悪影響を与え、また塗布後の肌にべたつきを生じて感触的に好ましくない場合がある。 As a preferable compounding quantity of the polyhydric alcohol in this invention, it is 1-20% in the whole composition, Most preferably, it is 5-15%. If the blending amount of the polyhydric alcohol is less than 1%, foam creamy and moderate foam stability cannot be obtained, and the moist feeling of the skin after application may be insufficient, resulting in stickiness. On the other hand, if the amount exceeds 20%, the foaming properties are adversely affected, and the skin after application may become sticky, which may be unpleasant to the touch.
本発明はさらに成分(D)グリコサミノグリカン類を配合することが本発明の効果の点から好ましい。グリコサミノグリカン類は、泡沫状化粧水の皮膚等へののびや広がり性を改善し、水分保持作用を有し、皮膚に潤いを与える保湿成分として配合される。グリコサミノグリカン類は、酸性ムコ多糖とも呼ばれ、ウロン酸又はガラクトースがアミノ糖と結合した二糖構造が繰り返して構成される高分子多糖類である。ウロン酸として、グルクロン酸及びイズロン酸が挙げられる。アミノ糖として、グルコサミン及びガラクトサミンが挙げられる。グリコサミノグリカン類の分子量としては、特に限定されるものではないが10万〜250万の範囲が好ましい。 In the present invention, it is preferable from the viewpoint of the effect of the present invention that a component (D) glycosaminoglycan is further blended. Glycosaminoglycans are formulated as moisturizing ingredients that improve the spread and spreadability of foamy skin lotion to the skin, have a moisture retention effect, and moisturize the skin. Glycosaminoglycans are also called polymeric mucopolysaccharides, and are high molecular polysaccharides composed of a disaccharide structure in which uronic acid or galactose is bound to an amino sugar. Examples of uronic acid include glucuronic acid and iduronic acid. Examples of amino sugars include glucosamine and galactosamine. Although it does not specifically limit as molecular weight of glycosaminoglycan, The range of 100,000-2 million is preferable.
グリコサミノグリカン類としては、例えばヒアルロン酸、コンドロイチン、コンドロイチン硫酸、デルマタン硫酸、ケラタン硫酸、ヘパラン硫酸、ヘパリン、及びそれらの塩類や誘導体が挙げられる。塩類としては、ナトリウム塩、カリウム塩等のアルカリ金属塩、トリエタノールアミン塩、キトサン塩、リシン・アルギニン等の塩基性アミノ酸との塩等が挙げられる。 Examples of glycosaminoglycans include hyaluronic acid, chondroitin, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparan sulfate, heparin, and salts and derivatives thereof. Examples of the salts include alkali metal salts such as sodium salt and potassium salt, salts with basic amino acids such as triethanolamine salt, chitosan salt and lysine / arginine.
ヒアルロン酸は、グルクロン酸にN−アセチルグルコサミンが結合した構造を繰り返し単位として構成されている。コンドロイチン及びコンドロイチン硫酸は、グルクロン酸とN−アセチルガラクトサミンとが結合した構造を繰り返し単位として構成されている。ケラタン硫酸は、ガラクトースとN−アセチルグルコサミンとが結合した構造を主要な繰り返し単位として構成されている。ヘパラン硫酸及びヘパリンは、グルクロン酸、イズロン酸、及びグルコサミンからなる多糖のN−硫酸、N−アセチル、及びO−硫酸置換体である。デルマタン硫酸は、イズロン酸とN−アセチルガラクトサミンとが結合した構造、及びグルクロン酸とN−アセチルガラクトサミンとが結合した構造を主要な繰り返し単位として構成されている。 Hyaluronic acid has a structure in which N-acetylglucosamine is bound to glucuronic acid as a repeating unit. Chondroitin and chondroitin sulfate are constituted with a structure in which glucuronic acid and N-acetylgalactosamine are bound as a repeating unit. Keratan sulfate has a structure in which galactose and N-acetylglucosamine are bonded as a main repeating unit. Heparan sulfate and heparin are N-sulfate, N-acetyl, and O-sulfate substitutes of polysaccharides consisting of glucuronic acid, iduronic acid, and glucosamine. Dermatan sulfate is composed mainly of a structure in which iduronic acid and N-acetylgalactosamine are bonded and a structure in which glucuronic acid and N-acetylgalactosamine are bonded.
これらのグリコサミノグリカン類の具体例は、単独で使用されてもよいし、二種以上が組み合わされて使用されてもよい。これらの具体例の中でも、皮膚に対して水分保持効果がより高いヒアルロン酸ナトリウム、ヒアルロン酸ヒドロキシプロピルトリモニウム、加水分解ヒアルロン酸、コンドロイチン硫酸ナトリウム、水溶性プロテオグリカンがより好ましい。 Specific examples of these glycosaminoglycans may be used alone or in combination of two or more. Among these specific examples, sodium hyaluronate, hydroxypropyltrimonium hyaluronate, hydrolyzed hyaluronic acid, sodium chondroitin sulfate, and water-soluble proteoglycan having a higher moisture retention effect on the skin are more preferable.
本発明におけるグリコサミノグリカン類の好ましい配合量としては、全組成物中に0.001〜1%、より好ましくは0.01〜0.5%である。グリコサミノグリカン類の含有量が0.001%未満であると、泡沫状化粧水の伸ばしやすさや皮膚に対し水分保持効果を十分に発揮することができない場合がある。また0.5%を超えて配合すると、粘度上昇によりノンガスフォーマー容器での目詰まりや動作不良が発生し、配合量に見合った水分保持効果は得られない場合がある。 As a preferable compounding quantity of glycosaminoglycan in this invention, it is 0.001-1% in a whole composition, More preferably, it is 0.01-0.5%. If the content of glycosaminoglycans is less than 0.001%, the foamy lotion may not be sufficiently stretched and the moisture retention effect may not be sufficiently exerted on the skin. On the other hand, when the content exceeds 0.5%, clogging or malfunction in the non-gas former container may occur due to an increase in viscosity, and a moisture retention effect commensurate with the blending amount may not be obtained.
成分(A)〜(C)を含有する本発明の組成物は、常温(20℃)において、液状であある。また組成物の粘度は、ブルックフィールド型粘度計で計測した場合、粘度が30mP
a・s以下であることが好ましく、さらに10mPa・s以下であることが特に好ましい。高分子ポリマー類を配合した場合、低温下で増粘する傾向にあり、冬季等で通常に想定される低温下でも問題なく泡として吐出し使用するためには、冬季等の低温下と同じ条件下、例えば5℃においても30mPa・s以下が好ましく、より好ましくは10mPa・s〜10mPa・sがより好ましい。粘度が30mPa・sを超えると、ノンガスフォーマー容器を押すために強い力が必要となり、泡沫形成性が劣る傾向にある。
The composition of the present invention containing components (A) to (C) is liquid at ordinary temperature (20 ° C.). The viscosity of the composition is 30 mP when measured with a Brookfield viscometer.
It is preferably at most a · s, more preferably at most 10 mPa · s. When high molecular weight polymers are blended, the viscosity tends to increase at low temperatures. To discharge and use as foam without problems even at low temperatures normally assumed in winter, etc., the same conditions as at low temperatures in winter, etc. For example, 30 mPa · s or less is preferable at 5 ° C., more preferably 10 mPa · s to 10 mPa · s. When the viscosity exceeds 30 mPa · s, a strong force is required to push the non-gas former container, and the foam-forming property tends to be inferior.
本発明に用いられるノンガスフォーマー容器は、容器内の化粧水を空気と混合し、多孔質膜等の泡生成手段を通過させることにより発泡させ、噴出するものであり、LPGやDME等の噴射剤を使用しないものである。具体的には、ノズルを押すことにより泡を噴出するポンプ型泡沫吐出容器(ポンプフォーマー容器)、ボトル胴部を手で押すことにより泡を噴出するスクイズ型泡沫吐出容器(スクイズフォーマー容器)等を例示することができる。多孔質膜としては、例えばスポンジ、焼結体、ネット等が挙げられ、50〜400メッシュのものが好ましく、より好ましくは100〜300メッシュのものである。50メッシュ未満では孔が大きすぎて泡立ちが悪くなる場合があり、400メッシュ超では化粧水の目詰まりが生じる場合があり好ましくない。また多孔質膜は、1枚又は複数枚用いることができるが、経済性、及び良好な泡質を得るために、2枚であることが好ましい The non-gas former container used in the present invention is a foam which is made by mixing the skin lotion in the container with air and passing through a foam generating means such as a porous film, and jetting, such as LPG and DME. The agent is not used. Specifically, a pump-type foam discharge container (pump former container) that ejects foam by pushing a nozzle, and a squeeze-type foam discharge container (squeeze foam container) that ejects foam by manually pushing the bottle body Etc. can be illustrated. Examples of the porous film include a sponge, a sintered body, a net, and the like, and those having 50 to 400 mesh are preferable, and those having 100 to 300 mesh are more preferable. If it is less than 50 mesh, the pores may be too large and foaming may worsen, and if it exceeds 400 mesh, the lotion may be clogged. In addition, one or a plurality of porous membranes can be used, but in order to obtain economy and good foam quality, it is preferable that the number is two.
また本発明に用いられるノンガスフォーマー容器としては、特公昭52−16567号公報、実公昭60−24426号公報、実開昭62−103458号公報、実公昭62−42785号公報、実公昭62−42786号公報、実公昭62−42787号公報、実開昭58−174272号公報、実開平3−7963号公報、米国特許第4531659号公報、米国特許第3709437号公報等の明細書又は図面等に開示されている様な容器も用いることができ、これらノンガスフォーマー容器は市販されており、具体例を挙げると、ポンプフォーマーFS2、同FS5S、同M1、同FL5L、同G3(大和製罐社製)、F5Lポンプフォーマー、F6Lポンプフォーマー(東京ライト工業社製)等が例示される。 Non-gas former containers used in the present invention include Japanese Examined Patent Publication No. 52-16567, Japanese Utility Model Publication No. 60-24426, Japanese Utility Model Publication No. 62-103458, Japanese Utility Model Publication No. 62-42785, Japanese Utility Model Publication No. 62-. No. 42786, No. 62-42787, No. 58-174272, No. 3-7963, U.S. Pat. No. 4,531,659, U.S. Pat. No. 3,709,437, etc. Containers as disclosed can also be used, and these non-gas former containers are commercially available. Specific examples include pump formers FS2, FS5S, M1, FL5L, G3 (Daiwa Steel) Co., Ltd.), F5L pump former, F6L pump former (manufactured by Tokyo Light Industry Co., Ltd.) and the like.
本発明の泡沫状化粧水には、上記の成分に加えて、本発明の効果を損なわない範囲内で、化粧料に一般に配合し得る成分を任意に添加することができる。このような成分としては、例えば油脂、ロウ類、炭化水素油、エステル油、シリコーンなどの油性成分、高級アルコール、低級アルコールなどのアルコール類、天然水溶性高分子、半合成水溶性高分子、合成水溶性高分子などの高分子化合物、保湿剤、防腐剤、ビタミン類、消炎剤、美白剤、植物抽出物、賦活剤、血行促進剤、抗脂漏剤、無機の水溶性高分子、金属イオン封鎖剤などの各種薬剤が挙げられる。 In addition to the above-described components, the foam skin lotion of the present invention may optionally contain components that can be generally blended into cosmetics within a range that does not impair the effects of the present invention. Examples of such components include oily components such as fats and oils, waxes, hydrocarbon oils, ester oils, and silicones, alcohols such as higher alcohols and lower alcohols, natural water-soluble polymers, semi-synthetic water-soluble polymers, and synthetic compounds. Polymer compounds such as water-soluble polymers, moisturizers, preservatives, vitamins, anti-inflammatory agents, whitening agents, plant extracts, activators, blood circulation promoters, antiseborrheic agents, inorganic water-soluble polymers, metal ions Various drugs such as a blocking agent are included.
油脂としては、アボガド油、ツバキ油、月見草油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン等の液体油脂;カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油等の固体油脂などが例示される。ロウ類としては、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、POEコレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテルなどが例示される。炭化水素油としては、流動パラフィン、オゾケラ
イト、スクワラン、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックス等の油分が例示される。エステル油としては、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、12−ヒドロキシステアリル酸コレステリル、ジ−2−エチルヘキシル酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N−アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキシル酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキシル酸ペンタンエリスリトール、トリー2−エチルヘキシル酸グリセリン、トリイソステアリン酸トリメチロールプロパン、セチル2−エチルヘキサノエート、2−エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ−2−ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オイル、アセトグリセライド、パルミチン酸2−ヘプチルウンデシル、アジピン酸ジイソブチル、N−ラウロイル−L−グルタミン酸−2−クチルドデシルエステル、アジピン酸ジ−2−ヘプチルウンデシル、エチルラウレート、セバチン酸ジ−2−エチルヘキシル、ミリスチン酸2−ヘキシルデシル、パルミチン酸2−ヘキシルデシル、アジピン酸2−ヘキシルデシル、セバチン酸ジイソプロピル、コハク酸2−エチルヘキシル、酢酸エチル、酢酸ブチル、酢酸アミル、クエン酸トリエチル、クロタミトン(C13H17NO)などが例示される。シリコーンとしては、ジメチルポリシロキサン、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン等の鎖状ポリシロキサン;デカメチルポリシロキサン、ドデカメチルポリシロキサン、テトラメチルテトラハイドロジェンポリシロキサン等の環状ポリシロキサン;3次元網目構造を形成しているシリコ−ン樹脂、シリコーンゴムなどが例示される。
As fats and oils, avocado oil, camellia oil, evening primrose oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil , Safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnagiri oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin, trioctanoic acid glycerin, triisopalmitic acid Liquid fats such as glycerin; cacao butter, palm oil, horse fat, hydrogenated palm oil, palm oil, beef tallow, sheep fat, hydrogenated beef tallow, palm kernel oil, pork fat, beef bone fat, owl kernel oil, hydrogenated oil, cow leg Examples thereof include solid fats and oils such as fat, mole, and hardened castor oil. The waxes include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, whale wax, montan wax, nuka wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, lauryl hexyl, reduced lanolin, jojojo Examples include a wax, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, and the like. Examples of the hydrocarbon oil include oils such as liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, and microcrystalline wax. Ester oils include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyl decyl dimethyloctanoate, cetyl lactate, myristyl lactate, Lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearylate, ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester, monoisostearic acid N-alkyl glycol, dicaprate neopentyl glycol, malic acid diacid Isostearyl, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexylate, triisostearyl Trimethylolpropane acid, pentane erythritol tetra-2-ethylhexylate, glyceryl triethyl 2-ethylhexylate, trimethylolpropane triisostearate, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, glyceryl trimyristate, tri-2 -Heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleic acid oil, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid-2-octyldecyl ester, adipic acid di-2 -Heptyl undecyl, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldeadipate Le, sebacic acid diisopropyl, 2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, triethyl citrate, crotamiton (C 13 H 17 NO) and the like are exemplified. Examples of silicone include linear polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, and methylhydrogenpolysiloxane; cyclic polysiloxanes such as decamethylpolysiloxane, dodecamethylpolysiloxane, and tetramethyltetrahydrogenpolysiloxane; three-dimensional Examples thereof include silicone resin and silicone rubber forming a network structure.
高級アルコールとしては、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール等の直鎖アルコール;モノステアリルグリセリンエーテル(バチルアルコール)、2−デシルテトラデシノール、ラノリンアルコール、コレステロール、フィトステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等の分枝鎖アルコールなどが例示される。低級アルコールとしては、エタノール、プロパノール、イソプロパノール、イソブチルアルコール、t−ブチルアルコール等が挙げられる。 As higher alcohols, linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol; monostearyl glycerin ether (batyl alcohol), 2-decyltetradecinol, lanolin alcohol, Examples thereof include branched chain alcohols such as cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, and octyldodecanol. Examples of the lower alcohol include ethanol, propanol, isopropanol, isobutyl alcohol, t-butyl alcohol and the like.
天然水溶性高分子としては、アラアビアガム、トラガカントガム、ガラクタン、グアーガム、ローカストビーンガム、タマリントガム、キャロブガム、カラヤガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)等の植物系水溶性高分子;キサンタンガム、デキストラン、サクシノグルカン、ブルラン等の微生物系水溶性高分子;コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系水溶性高分子などが例示される。半合成水溶性高分子としては、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系水溶性高分子;メチルセルロース、ニトロセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロース(CMC)、結晶セルロース、セルロース末等のセルロース系水溶性高分子;アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系水溶性高分子などが例示される。合成水溶性高分子としては、ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニルピロリドン、カルボキシビニルポリマー(カーボポール)等のビニル系水溶性高分子;ポリエチレングリコール1,000、同6,000、同20,000等のポリオキシエチレン系水溶性高分子;ポリオキシエチレンポリオキシプロピレン共重合体
等の共重合系水溶性高分子;ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系水溶性高分子のほか、ポリエチレンイミン、カチオンポリマーなどが例示される。無機の水溶性高分子としては、ベントナイト、ケイ酸AlMg(ビーガム)、ラポナイト、ヘクトライト、無水ケイ酸などが例示される。
Natural water-soluble polymers include arabia gum, tragacanth gum, galactan, guar gum, locust bean gum, tamarint gum, carob gum, caraya gum, carrageenan, pectin, agar, quince seed (malmello), alge colloid (gypsum extract), starch (rice, corn, Plant water-soluble polymers such as potato and wheat; microbial water-soluble polymers such as xanthan gum, dextran, succinoglucan, and bullulan; animal water-soluble polymers such as collagen, casein, albumin, and gelatin The Semi-synthetic water-soluble polymers include starch-based water-soluble polymers such as carboxymethyl starch and methylhydroxypropyl starch; methylcellulose, nitrocellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, hydroxypropylcellulose, carboxy Examples thereof include cellulose water-soluble polymers such as methyl cellulose (CMC), crystalline cellulose, and cellulose powder; and alginic acid water-soluble polymers such as sodium alginate and propylene glycol alginate. Synthetic water-soluble polymers include vinyl water-soluble polymers such as polyvinyl alcohol, polyvinyl methyl ether, polyvinyl pyrrolidone, and carboxyvinyl polymer (Carbopol); polyethylene glycol 1,000, 6,000, 20,000, etc. Polyoxyethylene water-soluble polymers; Copolymer water-soluble polymers such as polyoxyethylene polyoxypropylene copolymers; Acrylic water-soluble polymers such as sodium polyacrylate, polyethyl acrylate, and polyacrylamide , Polyethyleneimine, cationic polymer and the like. Examples of the inorganic water-soluble polymer include bentonite, silicate AlMg (beegum), laponite, hectorite, and silicic anhydride.
保湿剤としては、アテロコラーゲン、コレステリル−12−ヒドロキシステアレート、乳酸ナトリウム、胆汁酸塩、dl−ピロリドンカルボン酸塩、短鎖可溶性コラーゲン、イサイヨバラ抽出物、セイヨウノキギリソウ抽出物、メリロート抽出物などが例示される。ビタミン類としては、ビタミン油、レチノール、酢酸レチノール等のビタミンA類;リボフラビン、酪酸リボフラビン、フラビンアデニンヌクレオチド等のビタミンB2類;ピリドキシン塩酸塩、ピリドキシンジオクタノエート等のビタミンB6類;L−アスコルビン酸、L−アスコルビン酸ジパルミチン酸エステル、L−アスコルビン酸−2−硫酸ナトリウム、L−アスコルビン酸リン酸エステルDL−α−トコフェロール−L−アスコルビン酸リン酸ジエステルジカリウム、エチルアスコルビン酸等のビタミンC類;パントテン酸カルシウム、D−パントテニルアルコール、パントテニルエチルエーテル、アセチルパントテニルエチルエーテル等のパントテン酸類;エルゴカルシフェロール、コレカルシフェロール等のビタミンD類;ニコチン酸、ニコチン酸アミド、ニコチン酸ベンジル等のニコチン酸類;α−トコフェロール、酢酸トコフェロール、ニコチン酸DL−α−トコフェロール、コハク酸DL−α−トコフェロール等のビタミンE類;ビタミンP;ビオチンなど例示される。防腐剤としては、メチルパラベン、エチルパラベン、ブチルパラベン、プロピルパラベン、フェノキシエタノール、レゾルシン、サリチル酸、デヒドロ酢酸、ヘキサクロロフェン、塩化ベンザルコニウム、イソプロピルメチルフェノール、アルカンジオール等が例示される。消炎剤としては、グリチルリチン酸誘導体、グリチルレチン酸誘導体、サリチル酸誘導体、ヒノキチオール、酸化亜鉛、アラントイン等が例示される。美白剤としては、アスコルビン酸、アスコルビン酸誘導体、プラセンターエキス、アルブチン、トラネキサム酸、コウジ酸、イオウ、油溶性甘草抽出物、芍薬抽出物、ユキノシタ抽出物等が例示される。植物抽出物としては、オウバク、オウレン、シコン、シャクヤク、センブリ、バーチ、セージ、ビワ、ニンジン、アロエ、ゼニアオイ、アイリス、ブドウ、ヨクイニン、ヘチマ、ユリ、サフラン、センキュウ、ショウキュウ、オトギリソウ、オノニス、ローズマリー、ニンニク、トウガラシ、チンピ、トウキ、海藻、茶等の抽出物が例示される。賦活剤としては、ローヤルゼリー、感光素、コレステロール誘導体等が例示される。血行促進剤としては、ノニル酸ワレニルアミド、ニコチン酸ベンジルエステル、ニコチン酸β−ブトキシエチルエステル、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、カフェイン、タンニン酸、α−ボルネオール、ニコチン酸トコフェロール、イノシトールヘキサニコチネート、シクランデレート、シンナリジン、トラゾリン、アセチルコリン、ベラパミル、セファランチン、γ−オリザノール等が例示される。金属イオン封鎖剤としては、1−ヒドロキシエタン−1,1−ジホスホン酸、1−ヒドロキシエタン−1,1−ジホスホン酸四ナトリウム塩、エデト酸二ナトウム、エデト酸三ナトリウム、エデト酸四ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、リン酸、クエン酸、アスコルビン酸、コハク酸、エデト酸などが例示される。 Examples of moisturizing agents include atelocollagen, cholesteryl-12-hydroxystearate, sodium lactate, bile salts, dl-pyrrolidone carboxylate, short chain soluble collagen, Isaiyobara extract, Achillea millefactus extract, Merirot extract, etc. Illustrated. As vitamins, vitamin A such as vitamin oil, retinol, and retinol acetate; vitamin B 2 such as riboflavin, riboflavin butyrate, and flavin adenine nucleotide; vitamin B 6 such as pyridoxine hydrochloride and pyridoxine dioctanoate; L -Ascorbic acid, L-ascorbic acid dipalmitate, L-ascorbic acid-2-sodium sulfate, L-ascorbic acid phosphate DL-α-tocopherol-L-ascorbic acid diester dipotassium, ethylascorbic acid, etc. Vitamin Cs; pantothenic acids such as calcium pantothenate, D-pantothenyl alcohol, pantothenyl ethyl ether, acetyl pantothenyl ethyl ether; vitamin Ds such as ergocalciferol and cholecalciferol; Nicotinic acids such as cotic acid, nicotinic acid amide, benzyl nicotinate; vitamin E such as α-tocopherol, tocopherol acetate, DL-α-tocopherol nicotinate, DL-α-tocopherol succinate; vitamin P; exemplified by biotin The Examples of the preservative include methyl paraben, ethyl paraben, butyl paraben, propyl paraben, phenoxyethanol, resorcin, salicylic acid, dehydroacetic acid, hexachlorophene, benzalkonium chloride, isopropylmethylphenol, alkanediol and the like. Examples of the anti-inflammatory agent include glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin, and the like. Examples of the whitening agent include ascorbic acid, ascorbic acid derivatives, placenta extract, arbutin, tranexamic acid, kojic acid, sulfur, oil-soluble licorice extract, glaze extract, and yukinoshita extract. Plant extracts include: buckwheat, auren, shikon, peonies, assembly, birch, sage, loquat, carrot, aloe, mallow, iris, grape, yokoinin, loofah, lily, saffron, senkyu, ginger, hypericum, onion, rose Examples of the extract include marie, garlic, pepper, chimpi, toki, seaweed, and tea. Examples of the activator include royal jelly, photosensitizer, cholesterol derivative and the like. Blood circulation promoters include nonyl acid wallenyl amide, nicotinic acid benzyl ester, nicotinic acid β-butoxyethyl ester, capsaicin, gingerone, cantalis tincture, ictamol, caffeine, tannic acid, α-borneol, nicotinic acid tocopherol, inositol hexanicotine. Examples thereof include nate, cyclandrate, cinnarizine, trazoline, acetylcholine, verapamil, cephalanthin, and γ-oryzanol. The sequestering agents include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, edetate dinatium, edetate trisodium, edetate tetrasodium, Examples include sodium acid, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, and edetic acid.
本発明の泡沫状化粧水は皮膚または毛髪上に適用し、ノンガスフォーマーから吐出して生じた泡を皮膚または毛髪上に拡げることにより使用するのが好ましい。ここで皮膚上への適用手段としては、所望の皮膚上に直接吐出して、その場で泡を形成させてもよいが、手に吐出して泡を形成させ、その泡を所望の皮膚や毛髪上に塗布してもよい。本発明の泡沫状化粧水により形成された泡は数分間安定であり、皮膚上に拡げる操作、軽いマッサージ等を行っても安定である。 The foam lotion of the present invention is preferably used by applying on the skin or hair and spreading the foam generated by discharging from the non-gas former on the skin or hair. Here, as an application means on the skin, it may be directly discharged onto the desired skin to form bubbles on the spot, but it is discharged onto the hand to form bubbles, and the bubbles are formed on the desired skin or It may be applied on the hair. The foam formed with the foam lotion of the present invention is stable for several minutes, and is stable even when an operation for spreading on the skin, a light massage or the like is performed.
以下、試験方法と実施例をもって本発明をさらに詳しく説明する。本発明は、以下の試験方法や実施例によって何ら限定されるものではない。なお、以下の実施例において、配合割合は全て質量%である。 Hereinafter, the present invention will be described in more detail with reference to test methods and examples. The present invention is not limited by the following test methods and examples. In the following examples, the blending ratios are all mass%.
(1)起泡性、消泡性、べたつきのなさ、しっとり感の官能評価
10名の専門パネルを用いて、常法により調整した実施例および比較例の泡沫状化粧水を、ポンプフォーマーF5S(大和製罐(株)製)に充填し、泡沫を手のひらに吐出した後、顔面に塗布を行う官能試験を行い、起泡性、消泡性、べたつきのなさ、しっとり感の評価を行った。評価は、被験者本人が1点から5点の5段階にて、吐出直後の起泡性(泡立ちと泡沫のキメ細やかさ)、上腕内側部に塗布した際の消泡性(泡消えの丁度良さ)、使用後のべたつきのなさ、およびしっとり感について官能評価を行い、平均評価点を算出した。評価基準は以下の通りである。
(1) Sensory evaluation of foaming property, defoaming property, non-stickiness, moist feeling Using a professional panel of 10 persons, the foam lotions of Examples and Comparative Examples prepared by conventional methods were used as pump former F5S. After filling in (Daiwa Seisaku Co., Ltd.) and discharging foam onto the palm, a sensory test was performed to apply to the face, and foaming, defoaming, non-stickiness, and moist feeling were evaluated. . Evaluation was made by the subject himself in five stages, from 1 to 5, with foaming properties immediately after ejection (fineness of foaming and foaming) and defoaming properties when applied to the inner side of the upper arm (exactly good foam disappearance) ), Sensory evaluation was performed on the non-stickiness after use and the moist feeling, and the average evaluation score was calculated. The evaluation criteria are as follows.
(評価基準)
◎:平均点が4.0以上
〇:平均点が3.0以上、4.0未満
△:平均点が2.0以上、1.0未満
×:平均点が1.0未満
(Evaluation criteria)
◎: Average point is 4.0 or more ○: Average point is 3.0 or more and less than 4.0 △: Average point is 2.0 or more and less than 1.0 ×: Average point is less than 1.0
(2)低温下での泡沫形成性評価
常法により調整した実施例および比較例の泡沫状化粧水を、ポンプフォーマーF5S(大和製罐(株)製)に充填し、5℃の恒温下にて一昼夜放置し、ポンプを押して吐出るした際の泡のキメ細やかさを、室温に放置したものと一対比較した。評価基準は以下の通りである。
(2) Evaluation of foam formation at low temperature Foam lotions of Examples and Comparative Examples prepared by a conventional method are filled into a pump former F5S (manufactured by Yamato Seisaku Co., Ltd.) and kept at a constant temperature of 5 ° C. The fine texture of the foam when it was allowed to stand for a day and night and was discharged by pushing the pump was compared with a pair that was left at room temperature. The evaluation criteria are as follows.
(評価基準)
○:室温品と比較して泡のキメ細やかさが同じ
△:室温品と比較して泡のキメ細やかさがやや劣る
×:5℃保存品は泡立たない
(Evaluation criteria)
○: The fine texture of the foam is the same as the room temperature product. Δ: The fine texture of the foam is slightly inferior to the room temperature product.
(3)ポンプ詰まりの評価
常法により調整した実施例および比較例の泡沫状化粧水を、ポンプフォーマーF5S(大和製罐(株)製)に充填し、ポンプを10回押して泡沫を吐出させた後、一週間室温で放置して再度ポンプを押して使用し、ポンプ詰まりを評価した。評価基準は以下の通りである。
(3) Evaluation of pump clogging Foam lotion of Examples and Comparative Examples adjusted by a conventional method is filled in pump former F5S (manufactured by Yamato Seisaku Co., Ltd.) and the pump is pressed 10 times to discharge the foam. After that, it was allowed to stand at room temperature for one week and used again by pushing the pump to evaluate clogging of the pump. The evaluation criteria are as follows.
(評価基準)
○:詰まらない
△:若干のひっかかりがある
×:詰まる
(Evaluation criteria)
○: Not clogged △: Slightly caught ×: Clogged
実施例1〜17、比較例1〜8
表1〜3に示した泡沫状化粧水を調整し、ポンプフォーマーF5S(大和製罐(株)製)に充填し、上記各試験を実施した。その結果を表1〜3に併せて示す。
Examples 1-17, Comparative Examples 1-8
The foamy lotion shown in Tables 1 to 3 was prepared and filled into a pump former F5S (manufactured by Daiwa Steel Co., Ltd.), and the above tests were performed. The result is combined with Tables 1-3, and is shown.
表1〜表3から明らかなように本発明の成分を用いた実施例1〜17の泡沫状化粧水は、いずれも起泡性、消泡性、べたつきのなさ、しっとり感、低温下での起泡性および目詰まりのなさにおいて優れた性能を有していた。一方、必須成分のいずれかを欠いた比較例1〜8の泡沫状化粧水は、起泡性、消泡性、べたつきのなさ、しっとり感、低温下での起泡性および目詰まりのなさのいずれかの面で劣っており、本発明の目的を達成できなかった。 As apparent from Tables 1 to 3, the foam lotions of Examples 1 to 17 using the components of the present invention are all foaming properties, defoaming properties, non-stickiness, moist feeling, at low temperatures. It had excellent performance in terms of foamability and no clogging. On the other hand, the foam-like lotions of Comparative Examples 1 to 8 lacking any of the essential components have foaming properties, defoaming properties, non-stickiness, moist feeling, foaming properties at low temperatures and no clogging. It was inferior in any aspect, and the object of the present invention could not be achieved.
以下、本発明の泡沫状化粧水について、その他の処方例を実施例18〜19として挙げる。なお、これらの実施例の泡沫状化粧水についても、上記の起泡性、消泡性、べたつきのなさ、しっとり感、低温下での起泡性および目詰まりのなさについて各項目を評価したところ、いずれの実施例においても、優れた特性を有しており良好であった。 Hereinafter, about the foam-like lotion of this invention, other prescription examples are given as Examples 18-19. In addition, as for the foam lotion of these examples, each item was evaluated for the above-mentioned foaming property, defoaming property, non-stickiness, moist feeling, foaming property under low temperature and clogging. In any of the examples, the film had excellent characteristics and was good.
実施例18(泡沫状化粧水)
(1)デシルグルコシド 0.3%
(プランタケア2000、コグニスジャパン社製、純分50%)
(2)ポリオキシエチレン(60)硬化ヒマシ油 0.2%
(HLB値:14.0)
(3)モノステアリン酸デカグリセリル(HLB値:12.0) 0.1%
(4)オレイン酸ポリオキシエチレン(20)ソルビタン 0.1%
(HLB値:15.0)
(5)ジプロピレングリコール 3.0%
(6)1,3−ブチレングリコール 3.0%
(7)ポリエチレングリコール4000 2.0%
(8)グルコシルグリセリン 2.0%
(9)ヒアルロン酸ナトリウム 0.05%
(10)ヒアルロン酸ヒドロキシプロピルトリモニウム 0.5%
(ヒアロベール、キューピー社製)
(11)クエン酸 0.03%
(12)クエン酸ナトリウム 0.07%
(13)エデト酸二ナトリウム 0.05%
(14)ヒドロキシプロピルメチルセルロース 0.05%
(15)加水分解コラーゲン液 0.5%
(16)加水分解エラスチン液 0.5%
(17)エタノール 10.0%
(18)フェノキシエタノール 0.2%
(19)エチルヘキシルグリセリン 0.1%
(20)香料 0.02%
(21)精製水 残 部
Example 18 (foam lotion)
(1) Decyl glucoside 0.3%
(Planta Care 2000, manufactured by Cognis Japan, 50% pure)
(2) Polyoxyethylene (60) hydrogenated castor oil 0.2%
(HLB value: 14.0)
(3) Decaglyceryl monostearate (HLB value: 12.0) 0.1%
(4) Polyoxyethylene oleate (20) Sorbitan 0.1%
(HLB value: 15.0)
(5) Dipropylene glycol 3.0%
(6) 1,3-butylene glycol 3.0%
(7) Polyethylene glycol 4000 2.0%
(8) Glucosylglycerol 2.0%
(9) Sodium hyaluronate 0.05%
(10) Hydroxypropyltrimonium hyaluronate 0.5%
(Hiaroval, manufactured by Kewpie)
(11) Citric acid 0.03%
(12) Sodium citrate 0.07%
(13) Edetate disodium 0.05%
(14) Hydroxypropyl methylcellulose 0.05%
(15) Hydrolyzed collagen solution 0.5%
(16) Hydrolyzed elastin solution 0.5%
(17) Ethanol 10.0%
(18) Phenoxyethanol 0.2%
(19) Ethylhexylglycerin 0.1%
(20) Perfume 0.02%
(21) Balance of purified water
(製法)
(21)に(1)、(5)〜(16)を均一に溶解させたのち、(17)に(2)〜(4)および(18)〜(20)を混合したものを加え、粘度20mPa・sの組成物を作成し、ポンプフォーマーFL5L(大和製罐社製)に充填して泡沫状化粧水を調整した。
(Manufacturing method)
After (1) and (5) to (16) are uniformly dissolved in (21), a mixture of (2) to (4) and (18) to (20) is added to (17), and the viscosity A composition of 20 mPa · s was prepared and filled into a pump former FL5L (manufactured by Yamato Seisakusho) to prepare a foam lotion.
実施例19(ノンアルコールタイプ泡沫状化粧水)
(1)デシルグルコシド 0.5%
(マイドール10、花王社製、純分40%)
(2)ポリオキシエチレン(50)硬化ヒマシ油 0.3%
(HLB値:13.5)
(3)モノラウリン酸ポリオキシエチレン(4)ソルビタン 0.1%
(HLB値:13.3)
(4)ジプロピレングリコール 10.0%
(5)ポリエチレングリコール4000 1.0%
(6)グルコシルグリセリン 0.5%
(7)ヒアルロン酸ナトリウム 0.05%
(8)コンドロイチン硫酸ナトリウム 0.1%
(9)D−グルタミン酸 0.03
(10)クエン酸 0.02%
(11)クエン酸ナトリウム 0.08%
(12)エデト酸四ナトリウム 0.02%
(14)N−アセチルグルコサミン 0.5%
(15)加水分解コラーゲン液 0.5%
(16)加水分解エラスチン液 0.5%
(17)フェノキシエタノール 0.3%
(18)パラオキシ安息香酸メチル 0.1%
(19)香料 0.05%
(20)精製水 残 部
Example 19 (non-alcoholic foam lotion)
(1) Decyl glucoside 0.5%
(Mydoll 10, manufactured by Kao Corporation, 40% pure)
(2) Polyoxyethylene (50) hydrogenated castor oil 0.3%
(HLB value: 13.5)
(3) Polyoxyethylene monolaurate (4) Sorbitan 0.1%
(HLB value: 13.3)
(4) Dipropylene glycol 10.0%
(5) Polyethylene glycol 4000 1.0%
(6) Glucosylglycerin 0.5%
(7) Sodium hyaluronate 0.05%
(8) Sodium chondroitin sulfate 0.1%
(9) D-glutamic acid 0.03
(10) Citric acid 0.02%
(11) Sodium citrate 0.08%
(12) Tetosodium edetate 0.02%
(14) N-acetylglucosamine 0.5%
(15) Hydrolyzed collagen solution 0.5%
(16) Hydrolyzed elastin solution 0.5%
(17) Phenoxyethanol 0.3%
(18) Methyl paraoxybenzoate 0.1%
(19) Perfume 0.05%
(20) Balance of purified water
(製法)
(20)に(1)、(5)〜(16)を均一に溶解させたのち、60℃に加温した(4)に(2)(3)および(17)〜(19)を混合したものを加え、粘度5mPa・sの組成物を作成し、ポンプフォーマーF5S(大和製罐社製)に充填して泡沫状化粧水を調整した。
(Manufacturing method)
After (1) and (5) to (16) were uniformly dissolved in (20), (2) (3) and (17) to (19) were mixed with (4) heated to 60 ° C. A composition having a viscosity of 5 mPa · s was added and filled into a pump former F5S (manufactured by Yamato Seisakusho) to prepare a foam lotion.
実施例18及び19に用いた香料処方を以下に示す。 The perfume formulations used in Examples 18 and 19 are shown below.
Claims (2)
(A)アルキルポリグルコシド
(B)HLB値が12〜15の非イオン界面活性剤
(C)多価アルコール A non-gas former container was filled with a liquid composition containing the following components (A), (B) and (C) and having a total amount of (A) and (B) of 0.3 to 1% by mass. A foamy lotion characterized by that.
(A) Alkyl polyglucoside (B) Nonionic surfactant having an HLB value of 12 to 15 (C) Polyhydric alcohol
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012281098A JP6076080B2 (en) | 2012-12-25 | 2012-12-25 | Foam lotion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012281098A JP6076080B2 (en) | 2012-12-25 | 2012-12-25 | Foam lotion |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014125436A true JP2014125436A (en) | 2014-07-07 |
JP6076080B2 JP6076080B2 (en) | 2017-02-08 |
Family
ID=51405213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012281098A Active JP6076080B2 (en) | 2012-12-25 | 2012-12-25 | Foam lotion |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6076080B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016104661A1 (en) * | 2014-12-24 | 2016-06-30 | 株式会社ポーラファルマ | External composition for screen foamers |
KR20190075895A (en) | 2016-10-27 | 2019-07-01 | 가부시키가이샤 시세이도 | Bubble-shaped aqueous cosmetic |
JP2019172703A (en) * | 2016-06-16 | 2019-10-10 | 株式会社ポーラファルマ | Foam, composition for screen foamer, and method for evaluating the same |
JP2021038179A (en) * | 2019-09-05 | 2021-03-11 | 株式会社ノエビア | Skin external preparation |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08199188A (en) * | 1995-01-23 | 1996-08-06 | Chuo Aerosol Kagaku Kk | Raw solution for forming foam |
JP2003063928A (en) * | 2001-08-29 | 2003-03-05 | Pola Chem Ind Inc | Low foam type lotion composition |
JP2004035458A (en) * | 2002-07-03 | 2004-02-05 | Kanebo Ltd | Transparent liquid cosmetic |
JP2004277365A (en) * | 2003-03-18 | 2004-10-07 | Pola Chem Ind Inc | Foam forming composition for pump foamer |
JP2005023282A (en) * | 2003-07-04 | 2005-01-27 | Pigeon Corp | Foaming wipe-cleaning agent |
JP2008094840A (en) * | 2006-10-04 | 2008-04-24 | L'oreal Sa | Cleansing composition containing hollow hemisphere particle |
JP2009023980A (en) * | 2007-07-23 | 2009-02-05 | Rohto Pharmaceut Co Ltd | External preparation for skin |
JP2010024207A (en) * | 2008-07-23 | 2010-02-04 | Q P Corp | Liquid cosmetic filled in spray container |
JP2011012034A (en) * | 2009-07-06 | 2011-01-20 | Kao Corp | Cleaning agent |
-
2012
- 2012-12-25 JP JP2012281098A patent/JP6076080B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08199188A (en) * | 1995-01-23 | 1996-08-06 | Chuo Aerosol Kagaku Kk | Raw solution for forming foam |
JP2003063928A (en) * | 2001-08-29 | 2003-03-05 | Pola Chem Ind Inc | Low foam type lotion composition |
JP2004035458A (en) * | 2002-07-03 | 2004-02-05 | Kanebo Ltd | Transparent liquid cosmetic |
JP2004277365A (en) * | 2003-03-18 | 2004-10-07 | Pola Chem Ind Inc | Foam forming composition for pump foamer |
JP2005023282A (en) * | 2003-07-04 | 2005-01-27 | Pigeon Corp | Foaming wipe-cleaning agent |
JP2008094840A (en) * | 2006-10-04 | 2008-04-24 | L'oreal Sa | Cleansing composition containing hollow hemisphere particle |
JP2009023980A (en) * | 2007-07-23 | 2009-02-05 | Rohto Pharmaceut Co Ltd | External preparation for skin |
JP2010024207A (en) * | 2008-07-23 | 2010-02-04 | Q P Corp | Liquid cosmetic filled in spray container |
JP2011012034A (en) * | 2009-07-06 | 2011-01-20 | Kao Corp | Cleaning agent |
Non-Patent Citations (1)
Title |
---|
JPN6016016709; 阪本薬品工業株式会社ホームページ , 製品情報:Sフェイス * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10265268B2 (en) | 2014-12-24 | 2019-04-23 | Pola Pharma Inc. | External composition for screen foamers |
JP2016128424A (en) * | 2014-12-24 | 2016-07-14 | 株式会社ポーラファルマ | External composition for screen foamer |
WO2016104661A1 (en) * | 2014-12-24 | 2016-06-30 | 株式会社ポーラファルマ | External composition for screen foamers |
JP2016121146A (en) * | 2014-12-24 | 2016-07-07 | 株式会社ポーラファルマ | External composition for screen foamer |
JP2020073471A (en) * | 2014-12-24 | 2020-05-14 | 株式会社ポーラファルマ | External compositions for screen foamers |
JP2016128423A (en) * | 2014-12-24 | 2016-07-14 | 株式会社ポーラファルマ | External composition for screen foamer |
CN107106491A (en) * | 2014-12-24 | 2017-08-29 | 宝丽制药股份有限公司 | The topical composition of screen cloth bubbler |
JP2019196374A (en) * | 2014-12-24 | 2019-11-14 | 株式会社ポーラファルマ | External composition for screen foamer |
JP2016121145A (en) * | 2014-12-24 | 2016-07-07 | 株式会社ポーラファルマ | External composition for screen foamer |
JP2016121147A (en) * | 2014-12-24 | 2016-07-07 | 株式会社ポーラファルマ | Method for designing external composition for screen foamer |
JP2017214407A (en) * | 2014-12-24 | 2017-12-07 | 株式会社ポーラファルマ | External composition for screen foamer |
JP2019172703A (en) * | 2016-06-16 | 2019-10-10 | 株式会社ポーラファルマ | Foam, composition for screen foamer, and method for evaluating the same |
JP2020019784A (en) * | 2016-06-16 | 2020-02-06 | 株式会社ポーラファルマ | Composition for bubbles and screen former, and evaluation method thereof |
US11090234B2 (en) | 2016-06-16 | 2021-08-17 | Pola Pharma Inc. | Foam, screen foamer composition, and evaluation method for same |
KR20190075895A (en) | 2016-10-27 | 2019-07-01 | 가부시키가이샤 시세이도 | Bubble-shaped aqueous cosmetic |
JP2021038179A (en) * | 2019-09-05 | 2021-03-11 | 株式会社ノエビア | Skin external preparation |
JP7421289B2 (en) | 2019-09-05 | 2024-01-24 | 株式会社ノエビア | Skin external preparations |
Also Published As
Publication number | Publication date |
---|---|
JP6076080B2 (en) | 2017-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5995233B2 (en) | Foam aerosol composition | |
EP3530722B1 (en) | Detergent composition | |
US9757322B2 (en) | Liquid cosmetic | |
JP6076080B2 (en) | Foam lotion | |
KR20100050477A (en) | Alkylene oxide derivative and skin external preparation containing the same | |
KR20010101122A (en) | Skin preparations for external use | |
JP2013170145A (en) | Skin cosmetic composition | |
CN111741742A (en) | Sprayable compositions | |
JP5808709B2 (en) | Foam aerosol composition | |
DE102005013768A1 (en) | Foamable cosmetic compositions | |
JP6833476B2 (en) | Skin and head cleansing composition | |
JP7041646B2 (en) | Aerosol cosmetics | |
JP5658879B2 (en) | Aerosol skin cosmetics | |
TW202011936A (en) | Detergent composition | |
KR102617507B1 (en) | aerosol cosmetics | |
JP2019031456A (en) | Powder-containing aqueous composition and skin external preparation | |
WO2019244500A1 (en) | Oil-in-water type emulsion composition and production method therefor | |
JP2013237615A (en) | Foam aerosol composition | |
JP7262455B2 (en) | OIL-IN-WATER EMULSIFIED COSMETIC USING PARTIALLY CROSS-LINKED OR CROSS-LINKED DIMETHYPOLYSILOXANE | |
JP7359637B2 (en) | Cleaning compositions and cleaning products | |
WO2023053987A1 (en) | Cleansing agent | |
WO2023127484A1 (en) | Oil-in-water composition | |
JP2009143816A (en) | Skin care preparation | |
TW201944979A (en) | Detergent composition | |
WO2020175606A1 (en) | Composition for external preparation for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150708 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160412 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160511 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160706 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161019 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20161221 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170110 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6076080 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |